Results 11 to 20 of about 87,239 (208)

CHEMORADIOTHERAPY FOR COLORECTAL CANCER [PDF]

Gut, 2005
Recent estimates for cancer incidence and mortality in Europe continue to rank colorectal cancer as the second most common cause for cancer related death. Every year more than 376 000 patients are newly diagnosed with colorectal cancer and approximately 200 000 people die from the disease.1 Even though these numbers show a slight decrease,2,3 partially
N, Andre, W, Schmiegel
openaire   +2 more sources

Impact of Radiotherapy, Chemotherapy and Surgery in Multimodal Treatment of Locally Advanced Esophageal Cancer [PDF]

, 2011
Objectives: It was the aim of this study to assess our institutional experience with definitive chemoradiation (CRT) versus induction chemotherapy followed by CRT with or without surgery (C-CRT/S) in esophageal cancer.
Annina Lemminger, Stahlberg, Katharina, Lemminger, Annina, Claus Belka, Bleif, Martin, Bamberg, Michael, Katharina Stahlberg, Martin Bleif, Belka, Claus, Berger, Bernhard, Bernhard Berger, Michael Bamberg   +11 more
core   +1 more source

Chemoradiotherapy of esophageal carcinoma [PDF]

Cancer, 1994
Chemoradiotherapy has demonstrated efficacy in esophageal cancer but rarely is curative. To improve local control and decrease metastases, a 7-month regimen was used with standard-dose radiotherapy (RT), cisplatin (DDP), and continuous infusion (CI) 5-fluorouracil (5-FU) in patients with locoregional squamous/adenocarcinoma of the esophagus.Initial ...
E A, Poplin, P S, Khanuja, M J, Kraut, A M, Herskovic, P B, Lattin, G, Cummings, L E, Gaspar, J L, Kinzie, Z, Steiger, V K, Vaitkevicius   +9 more
openaire   +2 more sources

Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): A feasibility study [PDF]

, 2006
Background: Concurrent chemoradiotherapy has improved survival in inoperable stage III non-small cell lung cancer (NSCLC). This phase I trial was performed in order to establish a dose recommendation for oral vinorelbine in combination with cisplatin and
Schmidt, Michael, Aubert, Delphine, Flentje, Michael, Semrau, Sabine, Fietkau, Rainer, Fittipaldo, Alberto, Huber, Rudolf M., Kleine, Philip, Beckmann, Gabriele   +8 more
core   +1 more source

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Klautke, Gunther, Galle, Peter R., Brenner, Baruch, Arnold, Dirk, Roessler, Hans-Peter, Thomaidis, Thomas, Schimanski, Carl Christoph, Schmidberger, Heinz, Rödel, Claus, Gockel, Ines, Möhler, Markus, Trarbach, Tanja, Lang, Hauke   +12 more
core   +1 more source

The effects of cancer therapies on physical fitness before oesophagogastric cancer surgery: a prospective, blinded, multi-centre, observational, cohort study [version 1; peer review: 2 approved]

NIHR Open Research, 2021
Background: Neoadjuvant cancer treatment is associated with improved survival following major oesophagogastric cancer surgery. The impact of neoadjuvant chemo/chemoradiotherapy on physical fitness and operative outcomes is however unclear.
Lisa Loughney, Gareth Ambler, Thomas Owen, Michael G. Mythen, Denny Z.H. Levett, Gerard Danjoux, Jamie J. Kelly, Peter M.A. Calverley, Michael P.W. Grocott, Sandy Jack, Zachos Anastasiou, Malcolm A. West   +11 more
doaj   +1 more source

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer [PDF]

, 2012
BACKGROUND: The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population.
Bilgen, E.J.S., van Lanschot, J. J. B., Piet, A. H. M., Dekken, H. (Herman) van, Lanschot, J.J.B. van, Punt, C.J.A., Ten Kate, F.J.W., Spaander, Manon, Hospers, G.A.P. (Geke), Beukema, JC, Steyerberg, E.W., van Lanschot, Jan, Reinders, J.G., Hospers, G. A. P., van der Sangen, M.J.C., Hagen, P. (Pieter) van, van der Gaast, A., Wijnhoven, B.P.L., Kate, F.J.W. Ten, Wijnhoven, B.P.L. (Bas), Tilanus, H. W., Berge Henegouwen, M.I. (Mark) van, van Dekken, H (Herman), Rij, C. van, Nieuwenhuijzen, G.A.P., Piet, A.H.M., Cuesta, M.A. (Miguel), Creemers, G.-J., Henegouwen, MIV, Richel, D.J., Hulshof, M. C. C. M., Busch, O.R.C., Gaast, A. van der, Biermann, Katharina, Dekken, H. van, Verheul, HMW, Spillenaar Bilgen, E. J., ten Kate, F. J. W., van Rij, Caroline, Tilanus, H.W. (Hugo), Hulshof, MCCM, Wijnhoven, B. P. L., Plukker, J. T. M., Punt, CJA, Spillenaar Bilgen, E.J. (Ernst Jan), Biermann, K., Bonenkamp, J.J. (Han), Nieuwenhuijzen, G. A. P., Steyerberg, E. W., Bonenkamp, J.J., Rozema, T., Henegouwen, M. I. van Berge, Tilanus, H.W., van der Gaast, Ate, van Hagen, P., Sangen, M.J.C. van der, Bilgen, EJS, Busch, ORC, Punt, C.J.A. (Cornelis), van Dekken, H., Lanschot, J.J.B. (Jan) van, Busch, O. R. C., Plukker, JTM, Richel, DJ, Piet, AHM, Reinders, J.G.P. (Jurrien), Reinders, JG, Kate, Fiebo, van Rij, C., Busch, O.R.C. (Olivier), Cuesta, MA, Bilgen, E. J. Spillenaar, Nieuwenhuijzen, GAP, Beukema, J. C., Rozema, T. (Tom), Verheul, H.M.W. (Henk), Verheul, H. M. W., Creemers, G.J.M. (Geert-Jan), Gaast, A. (Ate) van der, Tilanus, Hugo, Hulshof, M.C.C.M. (Maarten), Bonenkamp, J. J., van Berge Henegouwen, M. I., Steyerberg, E.W. (Ewout), Punt, C. J. A., Richel, D. J., Beukema, J.C. (Jannet), Sangen, M.J.C. (Maurice) van der, Bonenkamp, JJ, Kate, F.J.W. (Fiebo) ten, Wijnhoven, Bas, Creemers, G.J., Verheul, H.M.W., Hagen, Pieter, Hospers, GAP, Blaisse, R. J. B., Rozema, T, Steyerberg, Ewout, Hagen, P. van, Rij, C.M. (Caroline) van, Cuesta, M. A., Hulshof, M.C.C.M., Plukker, J.T. (John), Cuesta, M.A., Blaisse, RJB, Henegouwen, M.I.V., Piet, A.H.M. (A. H M), Richel, D.J. (Dirk), van Rij, C. M., Beukema, J. C.; id_orcid, Blaisse, R.J.B., Hospers, G.A.P., Plukker, J.T.M., van Lanschot, J.J.B., van der Sangen, M. J. C., Creemers, GJ, Creemers, G. -J., Beukema, J.C., Reinders, J. G., Biermann, K. (Katharina), van der Sangen, MJC, Nieuwenhuijzen, G.A.P. (Gerard)   +121 more
core   +2 more sources

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma

Technology in Cancer Research & Treatment, 2021
Purpose: Induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone are both standard treatment regimens for managing locally advanced nasopharyngeal carcinoma.
Guoqiang Xu MD, Qiaoli Wang MD, Xingrao Wu MD, Chunyan Lv MD, Guilin Zeng MD, Zhihong Xue MD, Ruixue Cao MD, Nan Zhang BD, Wei Xiong PhD, Qin Huang MD   +9 more
doaj   +1 more source

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma

Frontiers in Oncology, 2021
PurposeTo identify whether chemoradiotherapy improves survival of stage I nasopharyngeal carcinoma (NPC).Materials and MethodsNPC patients were extracted from the Surveillance, Epidemiology, and End Results database between 2010 and 2015.
Jia-Lin Ma, Shi-Ting Huang, Yan-Ming Jiang, Xin-Bin Pan   +3 more
doaj   +1 more source

The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

Medicina, 2021
Background and Objectives: There is evidence or consensus on the use of 18F-2-fluorodeoxyglucose-positron emission tomography with computed tomography (PET-CT) in evaluating the effects of treatment at 12 weeks after chemoradiotherapy for head and neck ...
Hoshino Terada, Yuzo Shimode, Madoka Furukawa, Yuichiro Sato, Nobuhiro Hanai   +4 more
doaj   +1 more source